glp-1 afib Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study | Journal of General Internal Medicine GLP-1 Weight Loss & AFib

doi:.10.1111/ctr.13089 [PubMed: 28805261] [CrossRef] 177

The technology works in two ways, both effectively carrying the GLP-1 medication through the body and also painting the drug onto the antibodies

It started when the Pottsgrove, Pennsylvania, resident received a letter that her insurance company was no longer covering the GLP-1

Summary of the GLP-1 Receptor Agonist Market Market Definition The GLP-1 Receptor Agonist Market includes the development and sale of drugs that activate the glucagon-like peptide-1 (GLP-1) receptor, aimed at improving blood glucose control, reducing appetite, and supporting weight management in conditions such as type 2 diabetes and obesity

Why it happens: Weight loss and metabolic changes improve ovulation and fertility, especially in women with PCOS or obesity